Legend Biotech (LEGN) Current Assets (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Current Assets data on file, last reported at $1.2 billion in Q4 2025.

• In Q4 2025, Current Assets fell 2.87% year-over-year to $1.2 billion; the TTM figure through Dec 2025 stood at $1.2 billion (down 2.87% YoY), while the FY2025 annual figure was $1.2 billion, down 2.87% from the prior year.
• Current Assets steadied at $1.2 billion in Q4 2025, from $1.2 billion in the prior quarter.
• Across five years, Current Assets topped out at $1.6 billion in Q2 2023 and bottomed at $475074.0 in Q1 2021.
• A 5-year average of $1.1 billion and a median of $1.2 billion in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets soared 181849.97% — and 2024, when it retreated 14.28%.
• Year by year, Current Assets stood at $949.8 million in 2021, then increased by 15.72% to $1.1 billion in 2022, then surged by 36.27% to $1.5 billion in 2023, then dropped by 14.28% to $1.3 billion in 2024, then declined by 2.87% to $1.2 billion in 2025.
• The last three Current Assets figures came in at $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025), per Business Quant data.

Peer Comparison